Breakthrough Treatments for Small Cell Lung Cancer: Hope Through Clinical Trials

Small cell lung cancer was once considered one of the most challenging diagnoses in oncology. But today, groundbreaking treatments are transforming patient outcomes and rewriting survival stories. Discover how immunotherapy, T-cell engagers, CAR T-cell therapy, and antibody drug conjugates are moving from clinical trials to standard care, offering patients years of disease control and genuine hope for the future. Featuring insights from Dr. Jacob Sands, thoracic oncologist at Dana-Farber Cancer Institute, and inspiring patient advocate Wendy Brooks, who shares her powerful journey from early detection through cutting-edge clinical trials, proving that advocacy and hope can change everything.

Guests:

Dr. Jacob Sands, Oncologist, Dana-Farber Cancer Institute
Courtney Mantz, Program Manager II, SCLC Program, Dr. Sands’ Assistant. Dana-Farber Cancer Institute, Lowe Center for Thoracic Oncology
Wendy Brooks, Patient Advocate

Show Notes | Transcript | Watch Video